Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 3892933 | HLA-DR6 (BROAD ANTIGEN) | glomerulonephritis | NA | NA | NA | positive | |
| in the presentated statistics it can be shown, that in patients suffering from glomerulonephritis or pyelonephritis and requiring dialysis treatment the hla - drw6 antigen occur more frequently than in the control group of healthy blood donors. | |||||||
| 3892933 | HLA-DRB1*10 | glomerulonephritis | NA | NA | NA | unclassified | |
| in glomerulonephritis patients there is additionally a significant change in distribution favourable to hla - drw10 shown. | |||||||
| 3893108 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| while large multicenter studies show the continued importance of both transfusion and optimal hla matching, it has been argued that avoidance of pretransplant transfusions has avoided presentation of potential recipients, and that simplification of matching requirements has saved money and has permitted speedier transplantation of patients, favoring improved rehabilitation. | |||||||
| 3893108 | HLA-DR (HLA-DR) | cadaver | NA | NA | NA | unclassified | |
| both the experience of those centers that have been using it longest, and total us national experience, suggest that csa is now, with the sole exception of recipients matched for both hla-dr antigens, the immunosuppressive of choice for all cadaveric renal allografts, conferring approximately a 10% advantage in graft survival. | |||||||
| 3894417 | HLA-DR (HLA-DR) | transplantation | NA | NA | NA | unclassified | |
| we have now analyzed carotid artery plaques using a battery of antibodies against cell surface and cytoskeletal antigens, and found that most of the cells express the class ii transplantation antigen (ia antigen) hla-dr. also, the beta chain of hla-dr was detected by immunoblotting of plaque extracts with the okia1 monoclonal antibody. | |||||||
| 3894417 | HLA-DR (HLA-DR) | carotid artery plaques | NA | NA | NA | unclassified | |
| we have now analyzed carotid artery plaques using a battery of antibodies against cell surface and cytoskeletal antigens, and found that most of the cells express the class ii transplantation antigen (ia antigen) hla-dr. also, the beta chain of hla-dr was detected by immunoblotting of plaque extracts with the okia1 monoclonal antibody. | |||||||
| 3894417 | HLA-DR (HLA-DR) | atherosclerotic plaques | NA | NA | NA | unclassified | |
| this indicates that smooth muscle cells of atherosclerotic plaques express dr antigen. | |||||||
| 3897863 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | unclassified | |
| marrow transplantation from related donors other than hla-identical siblings. | |||||||
| 3897863 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| marrow transplantation has generally been limited to patients with a sibling who is genotypically identical for hla. | |||||||
| 3897863 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| thus, incompatibility for hla has an important effect on the course after clinical marrow transplantation. | |||||||
Copyright 2024